| Literature DB >> 2042056 |
Abstract
As determined in this study of 45 patients, the prolonged use of colchicine therapy in familial Mediterranean fever (FMF) is safe and effective in preventing flares of FMF and amyloidosis. It has acceptable adverse effect profile and can be used in children and pregnant women. Its discontinuation predisposes patients to acute FMF attacks and the development of amyloidosis. Articular involvement is less responsive to colchicine and may require therapy with nonsteroidal antiinflammatory drugs.Entities:
Mesh：
Substances：
Year: 1991 PMID： 2042056 DOI： 10.1016/0049-0172(91)90019-v
Source DB: PubMed Journal: Semin Arthritis Rheum ISSN： 0049-0172 Impact factor: 5.532